Skip to content
Disclosery

Mraz, Amerine & Associates, Inc.: CVE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Mraz, Amerine & Associates, Inc. on CVE, newest first. How the timeline and the estimate are built.

Mraz, Amerine & Associates, Inc. held 366,951 CVE shares at 2026-06-30 per its 13F-HR filed 2026-07-16.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 366,951 shares
    Change vs previous 13F +3,665 shares

    1.31% of the 13F portfolio, value $9,104,054.

    13F-HR 0001214659-26-008633 filed by Mraz, Amerine & Associates, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 363,286 shares
    Change vs previous 13F +68 shares

    1.42% of the 13F portfolio, value $9,637,978.

    13F-HR 0001214659-26-005580 filed by Mraz, Amerine & Associates, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 363,218 shares
    Change vs previous 13F -3,381 shares

    0.91% of the 13F portfolio, value $6,145,649.

    13F-HR 0001214659-26-001286 filed by Mraz, Amerine & Associates, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 366,599 shares
    Change vs previous 13F +35,201 shares

    0.97% of the 13F portfolio, value $6,228,517.

    13F-HR 0001214659-25-016025 filed by Mraz, Amerine & Associates, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 331,398 shares
    Change vs previous 13F +65,305 shares

    0.72% of the 13F portfolio, value $4,507,013.

    13F-HR 0001214659-25-010775 filed by Mraz, Amerine & Associates, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F/A 266,093 shares
    Change vs previous 13F +80,785 shares

    0.63% of the 13F portfolio, value $3,666,762.

    13F-HR/A 0001214659-25-010859 filed by Mraz, Amerine & Associates, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F/A 185,308 shares
    Change vs previous 13F +50,190 shares

    0.5% of the 13F portfolio, value $2,807,416.

    13F-HR/A 0001214659-25-010858 filed by Mraz, Amerine & Associates, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F/A 135,118 shares
    Change vs previous 13F not available

    0.41% of the 13F portfolio, value $2,260,524.

    13F-HR/A 0001214659-25-010857 filed by Mraz, Amerine & Associates, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).